nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP1A2—Pentoxifylline—systemic scleroderma	0.086	0.129	CbGbCtD
Ranitidine—CYP1A2—Leflunomide—systemic scleroderma	0.082	0.123	CbGbCtD
Ranitidine—ABCB1—Lisinopril—systemic scleroderma	0.0752	0.113	CbGbCtD
Ranitidine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0681	0.102	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—systemic scleroderma	0.0573	0.0859	CbGbCtD
Ranitidine—ABCB1—Captopril—systemic scleroderma	0.0563	0.0844	CbGbCtD
Ranitidine—CYP2D6—Captopril—systemic scleroderma	0.053	0.0795	CbGbCtD
Ranitidine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0443	0.0664	CbGbCtD
Ranitidine—CYP2C19—Prednisone—systemic scleroderma	0.0439	0.0658	CbGbCtD
Ranitidine—ABCB1—Prednisone—systemic scleroderma	0.0354	0.0531	CbGbCtD
Ranitidine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0266	0.0398	CbGbCtD
Ranitidine—CYP3A4—Prednisone—systemic scleroderma	0.0212	0.0318	CbGbCtD
Ranitidine—ABCB1—Methotrexate—systemic scleroderma	0.0178	0.0266	CbGbCtD
Ranitidine—Discomfort—Leflunomide—systemic scleroderma	0.000495	0.00149	CcSEcCtD
Ranitidine—Vomiting—Pentoxifylline—systemic scleroderma	0.000489	0.00147	CcSEcCtD
Ranitidine—Rash—Pentoxifylline—systemic scleroderma	0.000485	0.00146	CcSEcCtD
Ranitidine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000485	0.00146	CcSEcCtD
Ranitidine—Headache—Pentoxifylline—systemic scleroderma	0.000482	0.00145	CcSEcCtD
Ranitidine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000481	0.00144	CcSEcCtD
Ranitidine—Feeling abnormal—Captopril—systemic scleroderma	0.000481	0.00144	CcSEcCtD
Ranitidine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000478	0.00144	CcSEcCtD
Ranitidine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000478	0.00144	CcSEcCtD
Ranitidine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000478	0.00144	CcSEcCtD
Ranitidine—Vision blurred—Lisinopril—systemic scleroderma	0.000477	0.00143	CcSEcCtD
Ranitidine—Hypotension—Azathioprine—systemic scleroderma	0.000476	0.00143	CcSEcCtD
Ranitidine—Photosensitivity—Methotrexate—systemic scleroderma	0.000475	0.00143	CcSEcCtD
Ranitidine—Cardiac arrest—Prednisone—systemic scleroderma	0.000474	0.00143	CcSEcCtD
Ranitidine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000473	0.00142	CcSEcCtD
Ranitidine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000471	0.00141	CcSEcCtD
Ranitidine—Pruritus—Mometasone—systemic scleroderma	0.00047	0.00141	CcSEcCtD
Ranitidine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000469	0.00141	CcSEcCtD
Ranitidine—Tachycardia—Leflunomide—systemic scleroderma	0.000469	0.00141	CcSEcCtD
Ranitidine—Anaemia—Lisinopril—systemic scleroderma	0.000468	0.0014	CcSEcCtD
Ranitidine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000465	0.0014	CcSEcCtD
Ranitidine—Hepatic failure—Methotrexate—systemic scleroderma	0.000464	0.00139	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000464	0.00139	CcSEcCtD
Ranitidine—Angioedema—Lisinopril—systemic scleroderma	0.000462	0.00139	CcSEcCtD
Ranitidine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000462	0.00139	CcSEcCtD
Ranitidine—Abdominal pain—Captopril—systemic scleroderma	0.000461	0.00138	CcSEcCtD
Ranitidine—Body temperature increased—Captopril—systemic scleroderma	0.000461	0.00138	CcSEcCtD
Ranitidine—Nausea—Pentoxifylline—systemic scleroderma	0.000457	0.00137	CcSEcCtD
Ranitidine—Malaise—Lisinopril—systemic scleroderma	0.000456	0.00137	CcSEcCtD
Ranitidine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00137	CcSEcCtD
Ranitidine—Vertigo—Lisinopril—systemic scleroderma	0.000455	0.00137	CcSEcCtD
Ranitidine—Diarrhoea—Mometasone—systemic scleroderma	0.000454	0.00136	CcSEcCtD
Ranitidine—Leukopenia—Lisinopril—systemic scleroderma	0.000453	0.00136	CcSEcCtD
Ranitidine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00045	0.00135	CcSEcCtD
Ranitidine—Hypotension—Leflunomide—systemic scleroderma	0.000449	0.00135	CcSEcCtD
Ranitidine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000449	0.00135	CcSEcCtD
Ranitidine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000447	0.00134	CcSEcCtD
Ranitidine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000443	0.00133	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00044	0.00132	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000438	0.00132	CcSEcCtD
Ranitidine—Insomnia—Leflunomide—systemic scleroderma	0.000435	0.00131	CcSEcCtD
Ranitidine—Myalgia—Lisinopril—systemic scleroderma	0.000431	0.00129	CcSEcCtD
Ranitidine—Chest pain—Lisinopril—systemic scleroderma	0.000431	0.00129	CcSEcCtD
Ranitidine—Arthralgia—Lisinopril—systemic scleroderma	0.000431	0.00129	CcSEcCtD
Ranitidine—Dyspnoea—Leflunomide—systemic scleroderma	0.000428	0.00129	CcSEcCtD
Ranitidine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000428	0.00129	CcSEcCtD
Ranitidine—Discomfort—Lisinopril—systemic scleroderma	0.000426	0.00128	CcSEcCtD
Ranitidine—Pancreatitis—Prednisone—systemic scleroderma	0.000423	0.00127	CcSEcCtD
Ranitidine—Vomiting—Mometasone—systemic scleroderma	0.000422	0.00127	CcSEcCtD
Ranitidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000419	0.00126	CcSEcCtD
Ranitidine—Rash—Mometasone—systemic scleroderma	0.000419	0.00126	CcSEcCtD
Ranitidine—Dermatitis—Mometasone—systemic scleroderma	0.000418	0.00126	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000418	0.00125	CcSEcCtD
Ranitidine—Confusional state—Lisinopril—systemic scleroderma	0.000416	0.00125	CcSEcCtD
Ranitidine—Headache—Mometasone—systemic scleroderma	0.000416	0.00125	CcSEcCtD
Ranitidine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000415	0.00125	CcSEcCtD
Ranitidine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000413	0.00124	CcSEcCtD
Ranitidine—Pruritus—Captopril—systemic scleroderma	0.000413	0.00124	CcSEcCtD
Ranitidine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000411	0.00124	CcSEcCtD
Ranitidine—Constipation—Leflunomide—systemic scleroderma	0.000411	0.00123	CcSEcCtD
Ranitidine—Pain—Leflunomide—systemic scleroderma	0.000411	0.00123	CcSEcCtD
Ranitidine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00123	CcSEcCtD
Ranitidine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000409	0.00123	CcSEcCtD
Ranitidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000408	0.00122	CcSEcCtD
Ranitidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000407	0.00122	CcSEcCtD
Ranitidine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000405	0.00122	CcSEcCtD
Ranitidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000404	0.00121	CcSEcCtD
Ranitidine—Neutropenia—Prednisone—systemic scleroderma	0.000403	0.00121	CcSEcCtD
Ranitidine—Tachycardia—Lisinopril—systemic scleroderma	0.000403	0.00121	CcSEcCtD
Ranitidine—Abdominal pain—Azathioprine—systemic scleroderma	0.000402	0.00121	CcSEcCtD
Ranitidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000402	0.00121	CcSEcCtD
Ranitidine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0012	CcSEcCtD
Ranitidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000399	0.0012	CcSEcCtD
Ranitidine—Diarrhoea—Captopril—systemic scleroderma	0.000399	0.0012	CcSEcCtD
Ranitidine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000398	0.0012	CcSEcCtD
Ranitidine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000397	0.00119	CcSEcCtD
Ranitidine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000397	0.00119	CcSEcCtD
Ranitidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000396	0.00119	CcSEcCtD
Ranitidine—Nausea—Mometasone—systemic scleroderma	0.000394	0.00118	CcSEcCtD
Ranitidine—Pain—Mycophenolic acid—systemic scleroderma	0.000392	0.00118	CcSEcCtD
Ranitidine—Constipation—Mycophenolic acid—systemic scleroderma	0.000392	0.00118	CcSEcCtD
Ranitidine—Weight decreased—Prednisone—systemic scleroderma	0.00039	0.00117	CcSEcCtD
Ranitidine—Hypotension—Lisinopril—systemic scleroderma	0.000386	0.00116	CcSEcCtD
Ranitidine—Dizziness—Captopril—systemic scleroderma	0.000386	0.00116	CcSEcCtD
Ranitidine—Urticaria—Leflunomide—systemic scleroderma	0.000382	0.00115	CcSEcCtD
Ranitidine—Abdominal pain—Leflunomide—systemic scleroderma	0.00038	0.00114	CcSEcCtD
Ranitidine—Body temperature increased—Leflunomide—systemic scleroderma	0.00038	0.00114	CcSEcCtD
Ranitidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000378	0.00113	CcSEcCtD
Ranitidine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000377	0.00113	CcSEcCtD
Ranitidine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000377	0.00113	CcSEcCtD
Ranitidine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000377	0.00113	CcSEcCtD
Ranitidine—Breast disorder—Methotrexate—systemic scleroderma	0.000377	0.00113	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000376	0.00113	CcSEcCtD
Ranitidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000375	0.00113	CcSEcCtD
Ranitidine—Insomnia—Lisinopril—systemic scleroderma	0.000373	0.00112	CcSEcCtD
Ranitidine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00112	CcSEcCtD
Ranitidine—Vomiting—Captopril—systemic scleroderma	0.000371	0.00111	CcSEcCtD
Ranitidine—Dyspnoea—Lisinopril—systemic scleroderma	0.000368	0.00111	CcSEcCtD
Ranitidine—Rash—Captopril—systemic scleroderma	0.000368	0.0011	CcSEcCtD
Ranitidine—Dermatitis—Captopril—systemic scleroderma	0.000367	0.0011	CcSEcCtD
Ranitidine—Somnolence—Lisinopril—systemic scleroderma	0.000367	0.0011	CcSEcCtD
Ranitidine—Headache—Captopril—systemic scleroderma	0.000365	0.0011	CcSEcCtD
Ranitidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000365	0.0011	CcSEcCtD
Ranitidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000362	0.00109	CcSEcCtD
Ranitidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000362	0.00109	CcSEcCtD
Ranitidine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00109	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—systemic scleroderma	0.000357	0.00107	CcSEcCtD
Ranitidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00106	CcSEcCtD
Ranitidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000354	0.00106	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—systemic scleroderma	0.000353	0.00106	CcSEcCtD
Ranitidine—Constipation—Lisinopril—systemic scleroderma	0.000353	0.00106	CcSEcCtD
Ranitidine—Pain—Lisinopril—systemic scleroderma	0.000353	0.00106	CcSEcCtD
Ranitidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00106	CcSEcCtD
Ranitidine—Bradycardia—Prednisone—systemic scleroderma	0.000351	0.00106	CcSEcCtD
Ranitidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00035	0.00105	CcSEcCtD
Ranitidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000348	0.00105	CcSEcCtD
Ranitidine—Nausea—Captopril—systemic scleroderma	0.000346	0.00104	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000346	0.00104	CcSEcCtD
Ranitidine—Hallucination—Prednisone—systemic scleroderma	0.000343	0.00103	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—systemic scleroderma	0.000342	0.00103	CcSEcCtD
Ranitidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00034	0.00102	CcSEcCtD
Ranitidine—Pruritus—Leflunomide—systemic scleroderma	0.00034	0.00102	CcSEcCtD
Ranitidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00102	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—systemic scleroderma	0.000337	0.00101	CcSEcCtD
Ranitidine—Dizziness—Azathioprine—systemic scleroderma	0.000337	0.00101	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000332	0.000997	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00099	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000329	0.000988	CcSEcCtD
Ranitidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000329	0.000988	CcSEcCtD
Ranitidine—Urticaria—Lisinopril—systemic scleroderma	0.000328	0.000985	CcSEcCtD
Ranitidine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000327	0.000983	CcSEcCtD
Ranitidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000326	0.000981	CcSEcCtD
Ranitidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000326	0.000981	CcSEcCtD
Ranitidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000324	0.000974	CcSEcCtD
Ranitidine—Vomiting—Azathioprine—systemic scleroderma	0.000324	0.000972	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—systemic scleroderma	0.000323	0.000971	CcSEcCtD
Ranitidine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000969	CcSEcCtD
Ranitidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000966	CcSEcCtD
Ranitidine—Rash—Azathioprine—systemic scleroderma	0.000321	0.000964	CcSEcCtD
Ranitidine—Dermatitis—Azathioprine—systemic scleroderma	0.000321	0.000963	CcSEcCtD
Ranitidine—Headache—Azathioprine—systemic scleroderma	0.000319	0.000958	CcSEcCtD
Ranitidine—Dizziness—Leflunomide—systemic scleroderma	0.000318	0.000955	CcSEcCtD
Ranitidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000314	0.000942	CcSEcCtD
Ranitidine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000929	CcSEcCtD
Ranitidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000929	CcSEcCtD
Ranitidine—Arrhythmia—Prednisone—systemic scleroderma	0.000308	0.000926	CcSEcCtD
Ranitidine—Sweating—Methotrexate—systemic scleroderma	0.000308	0.000925	CcSEcCtD
Ranitidine—Vomiting—Leflunomide—systemic scleroderma	0.000306	0.000918	CcSEcCtD
Ranitidine—Alopecia—Prednisone—systemic scleroderma	0.000305	0.000916	CcSEcCtD
Ranitidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000304	0.000914	CcSEcCtD
Ranitidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000303	0.000911	CcSEcCtD
Ranitidine—Rash—Leflunomide—systemic scleroderma	0.000303	0.00091	CcSEcCtD
Ranitidine—Dermatitis—Leflunomide—systemic scleroderma	0.000303	0.000909	CcSEcCtD
Ranitidine—Nausea—Azathioprine—systemic scleroderma	0.000302	0.000908	CcSEcCtD
Ranitidine—Headache—Leflunomide—systemic scleroderma	0.000301	0.000904	CcSEcCtD
Ranitidine—Erythema—Prednisone—systemic scleroderma	0.000301	0.000903	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—systemic scleroderma	0.0003	0.000901	CcSEcCtD
Ranitidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000896	CcSEcCtD
Ranitidine—Pruritus—Lisinopril—systemic scleroderma	0.000292	0.000878	CcSEcCtD
Ranitidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000292	0.000876	CcSEcCtD
Ranitidine—Rash—Mycophenolic acid—systemic scleroderma	0.000289	0.000868	CcSEcCtD
Ranitidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000289	0.000867	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—systemic scleroderma	0.000289	0.000867	CcSEcCtD
Ranitidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000863	CcSEcCtD
Ranitidine—Headache—Mycophenolic acid—systemic scleroderma	0.000287	0.000863	CcSEcCtD
Ranitidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000859	CcSEcCtD
Ranitidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000859	CcSEcCtD
Ranitidine—Nausea—Leflunomide—systemic scleroderma	0.000285	0.000857	CcSEcCtD
Ranitidine—Vision blurred—Prednisone—systemic scleroderma	0.000283	0.000851	CcSEcCtD
Ranitidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000283	0.000849	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000279	0.000838	CcSEcCtD
Ranitidine—Anaemia—Prednisone—systemic scleroderma	0.000278	0.000834	CcSEcCtD
Ranitidine—Agitation—Prednisone—systemic scleroderma	0.000276	0.00083	CcSEcCtD
Ranitidine—Angioedema—Prednisone—systemic scleroderma	0.000275	0.000825	CcSEcCtD
Ranitidine—Dizziness—Lisinopril—systemic scleroderma	0.000273	0.00082	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000273	0.000819	CcSEcCtD
Ranitidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000272	0.000818	CcSEcCtD
Ranitidine—Malaise—Prednisone—systemic scleroderma	0.000271	0.000814	CcSEcCtD
Ranitidine—Vertigo—Prednisone—systemic scleroderma	0.00027	0.000811	CcSEcCtD
Ranitidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000801	CcSEcCtD
Ranitidine—Vomiting—Lisinopril—systemic scleroderma	0.000263	0.000789	CcSEcCtD
Ranitidine—Rash—Lisinopril—systemic scleroderma	0.00026	0.000782	CcSEcCtD
Ranitidine—Dermatitis—Lisinopril—systemic scleroderma	0.00026	0.000781	CcSEcCtD
Ranitidine—Headache—Lisinopril—systemic scleroderma	0.000259	0.000777	CcSEcCtD
Ranitidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000769	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—systemic scleroderma	0.000256	0.000768	CcSEcCtD
Ranitidine—Myalgia—Prednisone—systemic scleroderma	0.000256	0.000768	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—systemic scleroderma	0.000255	0.000766	CcSEcCtD
Ranitidine—Discomfort—Prednisone—systemic scleroderma	0.000253	0.000759	CcSEcCtD
Ranitidine—Erythema—Methotrexate—systemic scleroderma	0.000251	0.000754	CcSEcCtD
Ranitidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000744	CcSEcCtD
Ranitidine—Nausea—Lisinopril—systemic scleroderma	0.000245	0.000737	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000245	0.000737	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—systemic scleroderma	0.000239	0.000719	CcSEcCtD
Ranitidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000719	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000237	0.000712	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—systemic scleroderma	0.000237	0.000711	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000233	0.0007	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—systemic scleroderma	0.000232	0.000697	CcSEcCtD
Ranitidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000691	CcSEcCtD
Ranitidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000685	CcSEcCtD
Ranitidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000685	CcSEcCtD
Ranitidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000681	CcSEcCtD
Ranitidine—Malaise—Methotrexate—systemic scleroderma	0.000226	0.00068	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—systemic scleroderma	0.000226	0.000678	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—systemic scleroderma	0.000225	0.000675	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000223	0.000671	CcSEcCtD
Ranitidine—Insomnia—Prednisone—systemic scleroderma	0.000222	0.000666	CcSEcCtD
Ranitidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000646	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—systemic scleroderma	0.000214	0.000642	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—systemic scleroderma	0.000214	0.000642	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—systemic scleroderma	0.000214	0.000642	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—systemic scleroderma	0.000211	0.000635	CcSEcCtD
Ranitidine—Constipation—Prednisone—systemic scleroderma	0.00021	0.00063	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—systemic scleroderma	0.000207	0.000621	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000205	0.000616	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000202	0.000607	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000201	0.000603	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000198	0.000595	CcSEcCtD
Ranitidine—Urticaria—Prednisone—systemic scleroderma	0.000195	0.000585	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—systemic scleroderma	0.000194	0.000582	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—systemic scleroderma	0.000194	0.000582	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—systemic scleroderma	0.000192	0.000575	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000187	0.000561	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—systemic scleroderma	0.000185	0.000557	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—systemic scleroderma	0.000183	0.000549	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—systemic scleroderma	0.000182	0.000547	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisone—systemic scleroderma	0.000181	0.000543	CcSEcCtD
Ranitidine—Pain—Methotrexate—systemic scleroderma	0.000175	0.000526	CcSEcCtD
Ranitidine—Pruritus—Prednisone—systemic scleroderma	0.000174	0.000521	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000169	0.000507	CcSEcCtD
Ranitidine—Diarrhoea—Prednisone—systemic scleroderma	0.000168	0.000504	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—systemic scleroderma	0.000163	0.000489	CcSEcCtD
Ranitidine—Dizziness—Prednisone—systemic scleroderma	0.000162	0.000487	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000162	0.000487	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—systemic scleroderma	0.000162	0.000487	CcSEcCtD
Ranitidine—Vomiting—Prednisone—systemic scleroderma	0.000156	0.000468	CcSEcCtD
Ranitidine—Rash—Prednisone—systemic scleroderma	0.000155	0.000464	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—systemic scleroderma	0.000154	0.000464	CcSEcCtD
Ranitidine—Headache—Prednisone—systemic scleroderma	0.000154	0.000462	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000151	0.000454	CcSEcCtD
Ranitidine—Nausea—Prednisone—systemic scleroderma	0.000146	0.000438	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—systemic scleroderma	0.000145	0.000436	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—systemic scleroderma	0.00014	0.000421	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—systemic scleroderma	0.000136	0.000407	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—systemic scleroderma	0.00013	0.000391	CcSEcCtD
Ranitidine—Rash—Methotrexate—systemic scleroderma	0.000129	0.000388	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—systemic scleroderma	0.000129	0.000388	CcSEcCtD
Ranitidine—Headache—Methotrexate—systemic scleroderma	0.000128	0.000386	CcSEcCtD
Ranitidine—Nausea—Methotrexate—systemic scleroderma	0.000122	0.000366	CcSEcCtD
